Device reuse and SUDs on the agenda in Germany
This article was originally published in Clinica
The quality of refurbishment in Germany must be improved." So said Ulla Geibel, a delegate at a recent German MedInform device industry conference on medical device re-use/single use in the German market.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.